HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia
Isadora Lopes Cortez, Nicole Rodrigues da Silva, Naielly S. Rodrigues, João Francisco Cordeiro Pedrazzi, Elaine A. Del Bel, Raphael Mechoulam, Felipe V. Gomes, Francisco Silveira Guimarães
Topics & Concepts
CatalepsyPharmacologyAgonistCannabinoid receptorNMDA receptorCannabinoidPrepulse inhibitionAmphetaminePsychosisCannabinoid receptor type 2HaloperidolAntipsychoticDopaminergicPsychotomimeticSchizophrenia (object-oriented programming)PsychologyMedicineInternal medicineReceptorDopaminePsychiatryCannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment